First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 3.8 USD 8.57% Market Closed
Updated: May 14, 2024

Adaptive Biotechnologies Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptive Biotechnologies Corp
Capital Expenditures Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Capital Expenditures
-$9.3m
CAGR 3-Years
33%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.5B
CAGR 3-Years
0%
CAGR 5-Years
-14%
CAGR 10-Years
-18%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.4B
CAGR 3-Years
-15%
CAGR 5-Years
-16%
CAGR 10-Years
-10%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$99.5m
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
-2%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$312m
CAGR 3-Years
-35%
CAGR 5-Years
-15%
CAGR 10-Years
-6%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$649m
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-22%

See Also

What is Adaptive Biotechnologies Corp's Capital Expenditures?
Capital Expenditures
-9.3m USD

Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Capital Expenditures amounts to -9.3m USD.

What is Adaptive Biotechnologies Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
0%

Over the last year, the Capital Expenditures growth was 42%. The average annual Capital Expenditures growth rates for Adaptive Biotechnologies Corp have been 33% over the past three years .